FRANKLIN LAKES, N.J., May 28, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to initiate a patient data ...
The FDA is getting the word out on a high-risk issue related to artery-clearing catheters from BD’s Bard Peripheral Vascular division. According to the agency, BD has reported 30 serious injuries and ...
The FDA issued a warning regarding the Rotarex Atherectomy System, a device used to break up and remove the thrombus from peripheral arteries. Bard Peripheral Vascular, a subsidiary of Becton, ...
Becton, Dickinson and Company BDX, also popularly known as BD, recently received 510(k) clearance for expanded indications from the FDA for the Rotarex Atherectomy System. It is important to mention ...
BD is putting a fresh spin on an old awareness drive, returning to the 12-year-old “Love Your Limbs” campaign to mark Peripheral Artery Disease (PAD) Awareness Month. The company, which sells PAD ...
An atherectomy is a minimally invasive procedure to remove plaque buildup from an artery (blood vessel). Removing this plaque allows blood to flow more freely through the artery. An atherectomy treats ...
Dublin, March 04, 2020 (GLOBE NEWSWIRE) -- The "Atherectomy Devices Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global atherectomy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results